AstraZeneca To "Go It Alone" For Crestor, Cites Large Market Opportunity

AstraZeneca will pursue a solo marketing strategy for Crestor (rosuvastatin) based on the larger market outlined in recently issued cholesterol treatment guidelines.

More from Archive

More from Pink Sheet